Skip to main content

and
  1. No Access

    Article

    Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

    Schizophrenia is increasingly recognized as a neurodevelopmental disease with an additional degenerative component, comprising cognitive decline and loss of cortical gray matter. We hypothesized that a neuropr...

    H Ehrenreich, D Hinze-Selch, S Stawicki, C Aust, S Knolle-Veentjer in Molecular Psychiatry (2007)

  2. No Access

    Article

    Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects

    M A Dalal, A Schuld, T Pollmächer in Molecular Psychiatry (2003)